Seven out of the 18 menacing bacteria closely monitored by the Centers for Disease Control and Prevention (CDC) are evolving to resist the very antibiotics crucial for safeguarding public health. While this crisis looms on the horizon, pharmaceutical companies appear sluggish in producing new antibiotics capable of defeating these superbugs.
Astonishingly, fewer than 30 antibiotics are currently in development pipelines, specifically targeting the “priority” bacteria designated by the World Health Organization (WHO). Unfortunately, most of these drugs remain susceptible to resistance, mirroring the shortcomings of their predecessors.
Alternatives to fight superbugs
Amid this ominous backdrop, a cadre of scientists is venturing beyond conventional antibiotics in pursuit of innovative weapons that can combat superbugs without exacerbating the problem. Their burgeoning arsenal includes viruses designed to obliterate bacteria, the revolutionary CRISPR technology, and specialized microbe-slaying molecules. These experimental treatments, some of which have undergone patient testing, offer a glimmer of hope in the battle against superbugs.
Chase Beisel, leader of the RNA synthetic biology research group at the Helmholtz Institute for RNA-based Infection Research in Germany, shares this vision of a post-antibiotic era, stating, “The vision, for me, is that we move beyond antibiotics and really just see a much broader palate of options.” This perspective hints at a potentially transformative shift in how we combat infectious diseases.
Curbing overuse/misuse of antibiotics
However, until these groundbreaking therapeutics are ready for widespread use, the global community faces a pressing imperative: to curb the rampant overuse and misuse of antibiotics. Experts contend that this injudicious practice accelerates the rate at which these life-saving drugs become obsolete, heightening the urgency of finding effective alternatives.
The emergence of antibiotic-resistant superbugs represents a formidable challenge to public health, demanding swift and innovative solutions. While scientists diligently explore uncharted territory in the quest for new treatments, society must also take immediate action to preserve the efficacy of our existing antibiotic arsenal. The battle against superbugs rages on, and the outcome depends on our collective determination to stay one step ahead of these resilient foes.
Read More News
Fed court stalls grant program for female Black entrepreneurs
The photo above is from Pexels
